Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70421 ↗At a glance
Journal article in Clinical Transplantation, 2025. Written by Henrique M S Proença and 5 co-authors. Institution: Hospital Do Rim, Fundação Oswaldo Ramos, São Paulo, Brazil. Major MEDLINE topics: Kidney Transplantation, Graft Rejection, Tissue and Organ Procurement, Tissue Donors. Cited 1 times so far (Crossref); 25 references.
Abstract (original language)
Background
Procurement kidney biopsy has been used for over two decades, yet its value in guiding graft acceptance and allocation decisions remains debated. This study evaluated the performance of procurement biopsies in predicting kidney graft function within the first‐year post‐transplantation.
Methods
Retrospective cohort study including 339 procurement biopsies of kidneys transplanted between May 2018 and August 2019. All biopsies were paraffin embedded, stained (H&E, PAS, Jones Silver, and Masson's Trichrome), and prospectively analyzed and deemed suitable for transplantation by an experienced renal pathologist. All biopsies were retrospectively scored according to the Banff, Remuzzi, and MAPI classifications. Logistic regression was used to identify clinical and histological variables associated with unsatisfactory graft function, defined as eGFR
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Hospital Do Rim, Fundação Oswaldo Ramos, São Paulo, Brazil.
- Nephrology Division, Universidade Federal de São Paulo, São Paulo, Brazil.
- Faculdade De Medicina do ABC, Santo André, São Paulo, Brazil.
ORCID profiles: Henrique M S Proença, Lúcio Requião-Moura, Nicolas K Melaragno, Renato D Foresto, Jose O Medina Pestana, Helio Tedesco-Silva
Cite
APA
Proença, H. M. S., Requião-Moura, L., Melaragno, N. K., Foresto, R. D., Pestana, J. O. M., & Tedesco-Silva, H. (2025). Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.70421
Vancouver
Proença HMS, Requião-Moura L, Melaragno NK, Foresto RD, Pestana JOM, Tedesco-Silva H. Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation. Clinical Transplantation. 2025. doi:10.1111/ctr.70421
BibTeX
@article{Proena2025,
author = {Proença, Henrique M S and Requião-Moura, Lúcio and Melaragno, Nicolas K and Foresto, Renato D and Pestana, Jose O Medina and Tedesco-Silva, Helio},
title = {Procurement Kidney Biopsy and Donor Clinical Risk as Complementary Tools to Predict 3‐ and 12‐Month Graft Function After Transplantation},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70421}
}
EUVIMED